🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Nifty Closes The Week At All Time High, Pharma Stocks Shine

Published 25-08-2018, 09:15 am
MRCG
-

Pharma


Market Action - This Week (20-Aug-18 to 24-Aug-18)

This Week Index Performance


Nifty closes the week at all time high, Pharma stocks shine.The Indian Benchmark Index Nifty is trading at its all time high to close at 11557 after making a high of 11621. Benchmarks logged fifth weekly gain this week, the longest stretch of weekly gains in two months. This week the Index rose by 0.75% from its previous week. However, in the Indian Market, the Cash Market Index Small Cap underperformed Nifty and closed flat at 7532 after making a high of 7542.
Investors hoping for a global-trade resolution were left disappointed after the U.S. talks with China ended with an increased likelihood that tit-for-tat tariffs will escalate, casting a shadow over the global-growth outlook.
Among the sectoral performance pharma stocks shine, the sector rose by 3.83% followed by power which rose by 2.09%. Sequent Scientific (was up by 44.47%), Shilpa Medicare (was up by 17.11%), Merck (NS:MERK) (was up by 14.87%) and Marksans Pharma (was up by 14.66%).

Sectors performance in the current week

Sectors performance in the current week

Sector wise Small Cap Gainers in the current week

Sector wise Small Cap Gainers in the current week

Large cap Gainers & Losers in the current Week

Large cap Gainers & Losers in the current Week

Mid cap Gainers & Losers in the current week

Mid cap Gainers & Losers in the current week

Index Options


In the current Expiry, FII and PRO in combined have bought 86999 contracts in Index Options.Index Options

FII and DII activity in Cash Segment


In the current month DII have bought stocks in Cash segment worth Rs.2217.15 Crore.
FII and DII activity in Cash Segment

DISCLAIMER:
There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.